MRC Confidence in Concept (CiC)
the Medical Research Council (MRC) funded Confidence in Concept scheme is now open for applications, with up to £100k available per project. Queen’s was one of 14 UK research intensive Universities to be awarded the funding in September 2012.
The Biomedical Catalyst programme, announced by Prime Minister David Cameron in December 2011, is a programme of public funding designed to deliver growth to the UK Life Sciences sector. Delivered jointly by the MRC and the Technology Strategy Board, the Catalyst is a key feature of the UK Government’s Life Sciences Strategy.
A key component of the Biomedical Catalyst programme, and aligned with the MRC’s Translational Research Strategy, is the MRC Confidence in Concept scheme. The scheme is intended to accelerate the transition from discovery research to translational development projects by supporting preliminary work or feasibility studies to establish the viability of an approach.
Projects should aim to provide sufficient preliminary data to establish the viability of an approach to, for example, provide confidence in the underlying concept before seeking more substantive funding from sources such as the Developmental Pathway Funding Scheme/ Developmental Clinical Studies (DPFS/ DCS) or external investment from commercial partners. Funding for Confidence in Concept projects, lasting up to 12 months, is capped at £100k of eligible costs.
Deadlines for applications
- Monday 3rd December 2012 at 5pm
The final decision on the award will be made by the CiC Assessment Panel. It is anticipated that decisions on awards will be issued week commencing 17th Dec 2012.
The application process is outlined as follows:
- If you are considering an application, applicants are advised to discuss your idea with your nominated contact within the Commercial Development team (028 9097 2566 or email@example.com)
- Completed application forms should returned to firstname.lastname@example.org by 5 pm on Monday 3rd December 2012
- MRC CiC application form (MS Word)